Answers

What is an hs-CRP test, and what does it measure?

An hs-CRP result is one inflammation number on a lab report, usually printed in mg/L. Guidelines treat it as optional context for a risk discussion, not a diagnosis on its own, and one draw can mislead when you are not stable.

Arun Verma, co-founder of Triangle · 2026-10-19

This is not clinical evidence and not medical advice. It does not replace your care team. Discuss anything here with your clinician before you act on it.

What is an hs-CRP test?

An hs-CRP test is a blood test that measures very small amounts of C-reactive protein. MedlinePlus says a high-sensitivity CRP test measures very tiny increases in CRP levels and is used to estimate your risk of heart disease. It does not name a cause or a place in the body. MedlinePlus says CRP results tell you how much inflammation you have, but not what is causing it or where it is. A health care professional takes a blood sample from a vein in your arm; MedlinePlus says the process usually takes less than five minutes.

What is C-reactive protein?

C-reactive protein is a protein your liver makes when there is inflammation in the body. MedlinePlus says a CRP test measures the level of that protein in a blood sample. Other names on a report can include c-reactive protein or serum CRP. Healthy people usually have very low amounts; MedlinePlus cites a common healthy range for a standard CRP of about 0.8 to 1.0 mg/dL or lower (about 8 to 10 mg/L), which is a different scale from hs-CRP cutpoints reported in mg/L. Any rise above that range may mean inflammation is present, but the same page says the result still does not show the cause.

How does hs-CRP differ from a standard CRP test?

Both measure the same protein, but they are built for different jobs. MedlinePlus says a CRP test is sometimes confused with an hs-CRP test, and that they are used for different conditions. The high-sensitivity assay is the one meant for the low end of the scale. The AHA/CDC statement says hs-CRP results should be expressed as mg/L only, and that among inflammatory markers then available, hs-CRP had the assay characteristics most suited to practice. If a report shows mg/dL without calling out high-sensitivity, a fair question is whether the lab ran a standard CRP or an hs-CRP assay.

How do guidelines treat hs-CRP in risk assessment?

As optional context next to a full risk estimate, not as a stand-alone screen. The 2003 AHA/CDC statement endorses optional hs-CRP measurement in people without known CVD who sit at intermediate risk, about a 10% to 20% chance of coronary heart disease over 10 years, when a clinician wants more information for further evaluation or therapy decisions. It says the benefits of therapy based on that strategy remain uncertain. It recommends against screening the entire adult population for that purpose, and it discourages using hs-CRP as an alternative to major risk factors. The 2019 ACC/AHA primary-prevention guideline lists elevated high-sensitivity C-reactive protein of 2.0 mg/L or higher, if measured, among risk-enhancing factors for a clinician-patient risk discussion. Neither document treats a single hs-CRP number as a diagnosis.

What cutpoints do sources use?

Two schemes show up, and they are not the same line. The AHA/CDC statement groups hs-CRP as low under 1 mg/L, average 1.0 to 3.0 mg/L, and high above 3.0 mg/L. The 2019 ACC/AHA guideline uses a different marker on its risk-enhancing list: elevated hs-CRP at 2.0 mg/L or higher, if measured. A value can sit in the AHA/CDC average band and still meet or miss the 2.0 mg/L line, so a fair question is which scheme your report and your team use. A fair question for whoever ordered the test is which cutpoint they apply.

Why can one hs-CRP value mislead?

Because CRP jumps with acute inflammation, a single draw may not reflect your usual baseline. The AHA/CDC statement says the assay should be done in a metabolically stable person without obvious inflammatory or infectious conditions, that two assays averaged, fasting or nonfasting and optimally two weeks apart, give a more stable estimate, and that a result above 10 mg/L should be set aside, the person checked for an obvious source of inflammation, and the test repeated in two weeks. MedlinePlus also notes that some medicines and supplements can affect CRP results, A fair question is whether anything around the draw day could have moved the number. A fair question after a high result is whether a repeat is planned before anyone leans on the first value.

How do sources treat repeat testing over time?

For a baseline risk read, the AHA/CDC statement wants two measurements averaged, optimally two weeks apart, not a long series used to watch treatment. It rates serial testing of hs-CRP to monitor effects of treatment as something that should not be done. That leaves room for results from different years to sit in your file without turning each change into a treatment decision on its own. You could ask how your team wants a later value read next to an earlier one from the same kind of assay, whether both were high-sensitivity tests reported in mg/L, and whether a high result needs a repeat before anyone leans on it.

What could you ask about your hs-CRP result?

You could ask whether the order was a high-sensitivity assay or a standard CRP, which unit the report uses, whether a second draw is planned, and how the number sits with the rest of your risk picture. A fair question is which cutpoint your team uses, the AHA/CDC tertiles or the 2.0 mg/L risk-enhancing line in the 2019 ACC/AHA guideline. What a given hs-CRP means for a given person is a question for the people who know your history.

Sources

• MedlinePlus: C-Reactive Protein (CRP) Test: MedlinePlus says a high-sensitivity CRP (hs-CRP) test measures very tiny increases in CRP levels and is used to estimate your risk of heart disease.
• MedlinePlus: C-Reactive Protein (CRP) Test: MedlinePlus says CRP test results tell you how much inflammation you have in your body, but not what is causing it or where it is.
• MedlinePlus: C-Reactive Protein (CRP) Test: MedlinePlus says a health care professional will take a blood sample from a vein in your arm, and that this process usually takes less than five minutes.
• MedlinePlus: C-Reactive Protein (CRP) Test: MedlinePlus says a c-reactive protein test measures the level of c-reactive protein (CRP) in a sample of your blood, and that your liver makes CRP in response to inflammation.
• MedlinePlus: C-Reactive Protein (CRP) Test: MedlinePlus lists other names for the test as c-reactive protein and serum.
• MedlinePlus: C-Reactive Protein (CRP) Test: MedlinePlus says healthy people have very low amounts of CRP in their blood, and that a value of 0.8–1.0 mg/dL or lower is thought to be a healthy amount for a CRP test.
• MedlinePlus: C-Reactive Protein (CRP) Test: MedlinePlus says a CRP test is sometimes confused with a high-sensitivity (hs) CRP test, that they both measure CRP, and that they are used for different conditions.
• Pearson et al., Markers of Inflammation and Cardiovascular Disease: AHA/CDC Scientific Statement, Circulation 2003 (Table 4, Laboratory Testing): The AHA/CDC scientific statement says hs-CRP results should be expressed as mg/L only (Class I, Level of Evidence C).
• Pearson et al., Markers of Inflammation and Cardiovascular Disease: AHA/CDC Scientific Statement, Circulation 2003 (Table 4, Laboratory Testing): The AHA/CDC scientific statement says that of current inflammatory markers identified, hs-CRP has the analyte and assay characteristics most conducive to use in practice (Class IIa, Level of Evidence B).
• Pearson et al., Markers of Inflammation and Cardiovascular Disease: AHA/CDC Scientific Statement, Circulation 2003 (Table 4, Clinical Practice recommendation 1): The AHA/CDC scientific statement says measurement of hs-CRP is an independent marker of risk and, in those judged at intermediate risk by global risk assessment (10 to 20% risk of CHD per 10 years), at the discretion of the physician, may help direct further evaluation and therapy in the primary prevention of CVD, and that the benefits of such therapy based on this strategy remain uncertain (Class IIa, Level of Evidence B).
• Pearson et al., Markers of Inflammation and Cardiovascular Disease: AHA/CDC Scientific Statement, Circulation 2003 (Table 4, Population Science): The AHA/CDC scientific statement says the entire adult population should not be screened for hs-CRP for purposes of cardiovascular risk assessment (Class III, Level of Evidence C).
• Pearson et al., Markers of Inflammation and Cardiovascular Disease: AHA/CDC Scientific Statement, Circulation 2003 (Recommendations narrative): The AHA/CDC scientific statement says the Writing Group discourages use of hs-CRP as an alternative to major risk factors for risk assessment.
• 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, Circulation 2019 (Table 3, Risk-Enhancing Factors): The 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease lists, among risk-enhancing factors if measured, elevated high-sensitivity C-reactive protein (≥2.0 mg/L) (Table 3).
• Pearson et al., Markers of Inflammation and Cardiovascular Disease: AHA/CDC Scientific Statement, Circulation 2003 (Table 4, Laboratory Testing): The AHA/CDC scientific statement categorizes patients by average hs-CRP level using standardized assays as low <1 mg/L, average 1.0 to 3.0 mg/L, and high >3.0 mg/L (Class IIa, Level of Evidence B).
• Pearson et al., Markers of Inflammation and Cardiovascular Disease: AHA/CDC Scientific Statement, Circulation 2003 (Table 4, Laboratory Testing): The AHA/CDC scientific statement says measurement of markers should be done twice (averaging results), optimally two weeks apart, fasting or nonfasting in metabolically stable patients, and if hs-CRP level is >10 mg/L, the test should be repeated and the patient examined for sources of infection or inflammation (Class IIa, Level of Evidence B).
• MedlinePlus: C-Reactive Protein (CRP) Test: MedlinePlus says some medicines may affect CRP results and to tell your provider about any supplements or medicines that you take, and not to stop any prescription medicines without talking with your provider first.
• Pearson et al., Markers of Inflammation and Cardiovascular Disease: AHA/CDC Scientific Statement, Circulation 2003 (Table 4, Clinical Practice recommendation 9): The AHA/CDC scientific statement says serial testing of hs-CRP should not be used to monitor effects of treatment (Class III, Level of Evidence C).
• MedlinePlus: C-Reactive Protein (CRP) Test: MedlinePlus says any increases above normal may mean you have inflammation in your body.

Start your 7-day free trialLongform is made by Triangle. 7-day free trial, then $9 a month. Cancel anytime.